Vitamin D Status and Response to Supplementation as Predictive Factors for Early Remission in Polymyalgia Rheumatica: A Retrospective Longitudinal Investigation
Nutrients · 2025
DOI: 10.3390/nu17172839 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2025. Verfasst von Elvis Hysa und 11 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Experimental Rheumatology, Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genova, 16132 Gen…. Hauptthemen laut MEDLINE: Polymyalgia Rheumatica, Vitamin D, Dietary Supplements. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Polymyalgia rheumatica (PMR) is a relatively common inflammatory rheumatic disease of the elderly. The role of vitamin D remains unclear in this condition. The endpoints of this study were to assess 25-hydroxyvitamin D [25(OH)D] serum concentrations in PMR patients with active disease compared to elderly controls and to determine if baseline levels or changes following supplementation [delta 25-hydroxyvitamin D, Δ25(OH)D] were associated with improved clinical outcomes.
Methods
In this retrospective, case–control study, 29 PMR patients (55% males, 75.24 ± 9.6 years old, disease duration of 3.8 ± 3 months) were included, meeting the 2012 EULAR/ACR classification criteria, with 29 age- and sex-matched controls without systemic inflammatory rheumatic diseases. We assessed demographic, clinical and laboratory features for PMR patients, including baseline 25(OH)D serum concentrations, disease activity (polymyalgia rheumatica activity score), and serum inflammatory biomarkers. A subgroup of them (n = 25) was followed longitudinally, for an average period of 21.1 ± 17.7 months, to evaluate the association between Δ25(OH)D and clinical outcomes at follow-up using multivariate logistic regression.
Results
Although lower than the normal reference values, baseline 25(OH)D concentrations did not differ significantly between PMR patients and controls (21.6 ± 9.2 vs. 22.7 ± 11.3 ng/mL, p = 0.66) and did not predict long-term clinical outcomes. However, after only 3 months of supplementation, the increase in 25(OH)D concentrations was significantly associated with a remission status, and patients in remission showed a significant increase in 25(OH)D compared to those with persistent disease activity (+22.02 vs. +1.33 ng/mL, respectively; p = 0.044). Notably, in the multivariate model, this Δ25(OH)D was the strongest independent predictor of remission (OR = 2.89; 95% CI [1.60–4.11]), an effect independent of prednisone dosage prescribed at first visit (p = 0.32) and glucocorticoid exposure at third month (p = 0.12).
Conclusions
Individual’s response of PMR patients to supplementation of vitamin D seems to be a robust independent predictor of early clinical remission achievement. Interestingly, optimizing vitamin D supplementation based on individual responsiveness may represent a valuable adjunctive strategy in PMR management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Experimental Rheumatology, Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genova, 16132 Genova, Italy.
- Department of Experimental Medicine (DIMES), University of Genova, 16132 Genova, Italy.
- IRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy.
- Department of Internal Medicine, Ghent University, 9000 Ghent, Belgium.
- Department of Rheumatology, Ghent University Hospital, Corneel Heymanslaan 10, 9000 Ghent, Belgium.
- Unit for Molecular Immunology and Inflammation, VIB Inflammation Research Center (IRC), 9052 Ghent, Belgium.
ORCID-Profile: Elvis Hysa, Alberto Sulli, Maurizio Cutolo
Zitieren
APA
Hysa, E., Balito, S., Davoli, G., Caratto, E., Bernardi, G., Gotelli, E., Campitiello, R., Pizzorni, C., Paolino, S., Sulli, A., Smith, V., & Cutolo, M. (2025). Vitamin D Status and Response to Supplementation as Predictive Factors for Early Remission in Polymyalgia Rheumatica: A Retrospective Longitudinal Investigation. Nutrients. https://doi.org/10.3390/nu17172839
Vancouver
Hysa E, Balito S, Davoli G, Caratto E, Bernardi G, Gotelli E, et al. Vitamin D Status and Response to Supplementation as Predictive Factors for Early Remission in Polymyalgia Rheumatica: A Retrospective Longitudinal Investigation. Nutrients. 2025. doi:10.3390/nu17172839
BibTeX
@article{Hysa2025,
author = {Hysa, Elvis and Balito, Serena and Davoli, Giulia and Caratto, Elisa and Bernardi, Giulia and Gotelli, Emanuele and Campitiello, Rosanna and Pizzorni, Carmen and Paolino, Sabrina and Sulli, Alberto and Smith, Vanessa and Cutolo, Maurizio},
title = {Vitamin D Status and Response to Supplementation as Predictive Factors for Early Remission in Polymyalgia Rheumatica: A Retrospective Longitudinal Investigation},
journal = {Nutrients},
year = {2025},
doi = {10.3390/nu17172839}
}
EUVIMED